This collective work was published in 106 original articles and approximately fifty journals or book chapters and led to the team obtaining the FRM label. We will capitalize on the results obtained over the next five years by pursuing this translational approach and developing mechanistic aspects.
Moving forward, the role of the microbiota and intestine will be explored in the context of obesity progression and related complications, as well as the consequences of adipose tissue remodelling.
A bioinformatics approach using systems biology and data integration will be developed. An axis led by physicians in liaison with the clinical services associated with the team will aim to improve new therapeutic strategies by testing the relevance of the identified biomarkers/predictors in patients.